Karen-Sue Carlson, MD, PhD

Associate Professor

view physician profile

Locations

Froedtert Hospital
Cancer Center - Froedtert Hospital

Specialties

Medical Oncology
Hematology

Languages

English

Education

MD - Doctor of Medicine
PhD

Biography

Karen-Sue Barker Carlson, MD, PhD, is Assistant Professor of Medicine at the Medical College of Wisconsin, Division of Hematology and Oncology, specializing in acute and chronic myeloid leukemia, adolescent and young adult leukemia, myelodysplastic syndromes and myeloproliferative disorders. She received her MD and PhD in 2004 from the University of Wisconsin – Madison. In 2006, she completed her postdoctoral fellowship at The Rockefeller University in New York. She was awarded the F.M. Kirby Postdoctoral Fellowship in Sensory Neuroscience during her fellowship. Dr. Carlson completed her residency in internal medicine and subsequent Fellowship in Hematology and Medical Oncology at Weill Cornell Medical Center, New York Presbyterian Hospital, New York. In her final year, Dr. Carlson served as Chief Hematology and Oncology Fellow. Dr. Carlson held the position of Assistant Professor, Department of Medicine, Division of Hematology and Oncology at Weill Cornell Medical Center prior to joining MCW.

Research Interests

Dr. Carlson's basic and clinical research focus on the bone marrow microenvironment and its impact on normal and leukemic blood cell production. Dr. Carlson is board certified in Internal Medicine and Hematology.

Prognostic impact of serum CXC chemokine ligands 4 and 7 on myelodysplastic syndromes post allogeneic hematopoietic cell transplant.

(Dhakal B, Wang T, Kuxhausen M, Zhu F, Taylor C, Spellman SR, Verneris MR, Hsu K, Fleischhauer K, Lee SJ, Bolon YT, Carlson KS, Nazha A, Saber W.) Leuk Lymphoma. 2021 01;62(1):229-233 PMID: 32924688 PMCID: PMC7939047 SCOPUS ID: 2-s2.0-85090933926 09/15/2020
Single-cell transcriptome reveals the novel role of T-bet in suppressing the immature NK gene signature.

(Yang C, Siebert JR, Burns R, Zheng Y, Mei A, Bonacci B, Wang D, Urrutia RA, Riese MJ, Rao S, Carlson KS, Thakar MS, Malarkannan S.) Elife. 2020 05 14;9 PMID: 32406817 PMCID: PMC7255804 SCOPUS ID: 2-s2.0-85085630468 05/15/2020
Improving Outcomes of Acute Promyelocytic Leukemia in the Current Era: Analysis of the SEER Database.

(Guru Murthy GS, Szabo A, Michaelis L, Carlson KS, Runaas L, Abedin S, Atallah E.) J Natl Compr Canc Netw. 2020 02;18(2):169-175 PMID: 32023530 SCOPUS ID: 2-s2.0-85079065513 02/06/2020
Role of thrombomodulin expression on hematopoietic stem cells.

(Basu S, Liang HPH, Hernandez I, Zogg M, Fields B, May J, Ogoti Y, Wyseure T, Mosnier LO, Burns RT, Carlson K, Weiler H.) J Thromb Haemost. 2020 01;18(1):123-135 PMID: 31628891 PMCID: PMC6940513 SCOPUS ID: 2-s2.0-85074837812 10/20/2019
The Adult Murine Intestine is Dependent on Constitutive Laminin-γ1 Synthesis.

(Fields B, DeLaForest A, Zogg M, May J, Hagen C, Komnick K, Wieser J, Lundberg A, Weiler H, Battle MA, Carlson KS.) Sci Rep. 2019 12 17;9(1):19303 PMID: 31848396 PMCID: PMC6917708 SCOPUS ID: 2-s2.0-85076615345 12/19/2019
Heterogeneity of human bone marrow and blood natural killer cells defined by single-cell transcriptome.

(Yang C, Siebert JR, Burns R, Gerbec ZJ, Bonacci B, Rymaszewski A, Rau M, Riese MJ, Rao S, Carlson KS, Routes JM, Verbsky JW, Thakar MS, Malarkannan S.) Nat Commun. 2019 09 02;10(1):3931 PMID: 31477722 PMCID: PMC6718415 SCOPUS ID: 2-s2.0-85071610251 09/04/2019
Critical role of Jumonji domain of JMJD1C in MLL-rearranged leukemia.

(Izaguirre-Carbonell J, Christiansen L, Burns R, Schmitz J, Li C, Mokry RL, Bluemn T, Zheng Y, Shen J, Carlson KS, Rao S, Wang D, Zhu N.) Blood Adv. 2019 05 14;3(9):1499-1511 PMID: 31076406 PMCID: PMC6517669 SCOPUS ID: 2-s2.0-85068626845 05/12/2019
Stem cell damage after chemotherapy- can we do better?

(Tang J, Zhu N, Rao S, Carlson KS.) Best Pract Res Clin Haematol. 2019 03;32(1):31-39 PMID: 30927973 SCOPUS ID: 2-s2.0-85061244660 04/01/2019
Early Fluorescence in situ Hybridization Assessment during Acute Myeloid Leukemia Induction Chemotherapy

(Schneidewend R · Hosking P · Brazauskas R · Peterson J · Beaudin C · Michaelis L · Atallah E · Hari P · Carlson K.) Acta Haematologica. Acta Haematol 2018;139:171–175 03/29/2018
Early mortality in patients with acute myelogenous leukemia treated in teaching versus non-teaching hospitals: A large database analysis.

(Levin A, Kleman A, Rein L, Tarima S, Michaelis LC, Carlson KS, Hamadani M, Fenske TS, Hari P, Atallah E, Dhakal B.) Am J Hematol. 2017 Sep;92(9):E563-E565 PMID: 28631379 SCOPUS ID: 2-s2.0-85021972988 06/21/2017
Recipient Immune Modulation with Atorvastatin for Acute Graft-versus-Host Disease Prophylaxis after Allogeneic Transplantation.

(Kanate AS, Hari PN, Pasquini MC, Visotcky A, Ahn KW, Boyd J, Guru Murthy GS, Rizzo JD, Saber W, Drobyski W, Michaelis L, Atallah E, Carlson KS, D'Souza A, Fenske TS, Cumpston A, Bunner P, Craig M, Horowitz MM, Hamadani M.) Biol Blood Marrow Transplant. 2017 Aug;23(8):1295-1302 PMID: 28412518 SCOPUS ID: 2-s2.0-85019639994 04/17/2017
Variable phenotypic penetrance of thrombosis in adult mice after tissue-selective and temporally controlled Thbd gene inactivation.

(van Mens TE, Liang HH, Basu S, Hernandez I, Zogg M, May J, Zhan M, Yang Q, Foeckler J, Kalloway S, Sood R, Karlson CS, Weiler H.) Blood Adv. 2017 Jun 27;1(15):1148-1158 PMID: 28920104 PMCID: PMC5600150 09/19/2017